Health Viridian Therapeutics Secures Licensing Deal in Japan to Challenge Amgen Viridian Therapeutics has announced a significant licensing agreement in Japan, a leading pharmaceutical market, to advance its product aimed at competing with Amgen’s Tepezza.... Editorial1 day ago